Sign inJoin waitlistJoin the waitlist

GS

Guru Sonpavde

Physician · AdventHealth Central Florida Division

Credentials: · · · · · · ·

History

AdventHealth Central Florida Division
2022–Present

Medical Oncology
1993–1995
Internal Medicine
1990–1993
Doctor of Medicine
1986–1990

Research

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis
Systematic review or meta-analysis · Journal of the National Cancer Institute · 2014 · 2,646 citations
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
New England Journal of Medicine · 2021 · 1,024 citations
Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy
Review · Journal of Clinical Oncology · 2011 · 558 citations

Matthew Galsky
93 papers
Toni Choueiri
68 papers
Joaquim Bellmunt
56 papers
Neeraj Agarwal
45 papers
NH
Noah Hahn
39 papers · 1 as a fellow
Petros Grivas
35 papers
TH
Thomas Hutson
34 papers
Cora Sternberg
32 papers
JR
Jonathan Rosenberg
31 papers
SL
Seth Lerner
30 papers
Amin Nassar
27 papers · 24 as a resident
Bradley McGregor
27 papers

Grants

Integrative Molecular Dissection of Acquired Resistance to PD1/PD-L1 Blockade in Localized and Metastatic Urothelial Carcinoma
National Cancer Institute · R21
Contact PI · $476.3K · Dana-Farber Cancer Inst
2021–2023

Clinical trials

Phase I BLASST-3 Trial
Principal investigator · Withdrawn · Phase 1
Guru P. Sonpavde
2021–2023
Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients
Principal investigator · Active not recruiting · Phase 1, Phase 2
H. Lee Moffitt Cancer Center and Research Institute
2021–2027
Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment
Principal investigator · Completed · Phase 2
University of Alabama at Birmingham
2014–2017
Gemzar, Cisp, Sunitinib Urothelial Ca
Principal investigator · Completed · Phase 2
US Oncology Research
2008–2012